Track the 안지오랩 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 안지오랩 has recorded 24 public disclosures. The latest transaction was reported on 22 January 2026 (Sale). Among the most active insiders: 인터베스트. Every trade is accessible without an account.
24
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
13 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
안지오랩 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in developing innovative treatments for cardiovascular diseases.